The MDG Target 8.E contains a commitment, in cooperation with pharmaceutical companies, to provide access to affordable essential drugs in developing countries. However, the lack of quantitative targets and indicators in the MDG framework prevents proper monitoring of global commitments towards providing essential medicines, as well as an assessment of the contribution of the pharmaceutical sector.